{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:50:23Z","timestamp":1791859823870,"version":"4.3.4"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":221,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["16043"],"award-info":[{"award-number":["16043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1002\/da.22340","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T15:54:06Z","timestamp":1422028446000},"page":"167-173","source":"Crossref","is-referenced-by-count":104,"title":["PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL"],"prefix":"10.1155","volume":"32","author":[{"given":"Atefeh","family":"Zeinoddini","sequence":"first","affiliation":[{"name":"Psychiatric Research Center; Roozbeh Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Sorayani","sequence":"additional","affiliation":[{"name":"Psychiatric Research Center; Roozbeh Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Hassanzadeh","sequence":"additional","affiliation":[{"name":"Psychiatric Research Center; Roozbeh Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Arbabi","sequence":"additional","affiliation":[{"name":"Psychiatric Research Center; Roozbeh Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Farokhnia","sequence":"additional","affiliation":[{"name":"Psychiatric Research Center; Roozbeh Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrand","family":"Salimi","sequence":"additional","affiliation":[{"name":"Baharloo Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ghaleiha","sequence":"additional","affiliation":[{"name":"Research Center for Behavioral Disorders and Substance Abuse; Hamadan University of Medical Sciences; Hamadan Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[{"name":"Psychiatric Research Center; Roozbeh Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"10.1002\/da.22340-BIB0001|da22340-cit-0001","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4088\/JCP.v65n1109","article-title":"Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample","volume":"65","author":"Calabrese","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1002\/da.22340-BIB0002|da22340-cit-0002","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v68n0811","article-title":"Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression","volume":"68","author":"Simon","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22340-BIB0003|da22340-cit-0003","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.22340-BIB0004|da22340-cit-0004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"10.1002\/da.22340-BIB0005|da22340-cit-0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.05.018","article-title":"New treatment guidelines for acute bipolar depression: a systematic review","volume":"129","author":"Nivoli","year":"2011","journal-title":"J Affect Disord"},{"issue":"4 Suppl","key":"10.1002\/da.22340-BIB0006|da22340-cit-0006","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"Association","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22340-BIB0007|da22340-cit-0007","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v69n0610","article-title":"Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22340-BIB0008|da22340-cit-0008","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.292.3.338","article-title":"Antidepressants and the risk of suicidal behaviors","volume":"292","author":"Jick","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/da.22340-BIB0009|da22340-cit-0009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1002\/da.22340-BIB0010|da22340-cit-0010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"10.1002\/da.22340-BIB0011|da22340-cit-0011","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2009.04.011","article-title":"A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis","volume":"211","author":"Kaiser","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1002\/da.22340-BIB0012|da22340-cit-0012","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1345\/aph.1Q238","article-title":"Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease","volume":"45","author":"Miller","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1002\/da.22340-BIB0013|da22340-cit-0013","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jad.2011.06.033","article-title":"Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity","volume":"136","author":"Kemp","year":"2012","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1002\/da.22340-BIB0014|da22340-cit-0014","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40263-014-0158-2","article-title":"PPAR-gamma agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression","volume":"28","author":"Kemp","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1002\/da.22340-BIB0015|da22340-cit-0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1399-5618.2010.00823.x","article-title":"Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine\/metabolic system and treatment outcome","volume":"12","author":"Kemp","year":"2010","journal-title":"Bipolar Disord"},{"issue":"5","key":"10.1002\/da.22340-BIB0016|da22340-cit-0016","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/appi.ajp.2008.08081195","article-title":"Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome","volume":"166","author":"Kemp","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22340-BIB0017|da22340-cit-0017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4088\/JCP.v69n0202","article-title":"Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study","volume":"69","author":"Koponen","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22340-BIB0018|da22340-cit-0018","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/sj.npp.1301652","article-title":"Novel drugs and therapeutic targets for severe mood disorders","volume":"33","author":"Mathew","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.22340-BIB0019|da22340-cit-0019","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-012-2722-0","article-title":"NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice","volume":"223","author":"Salehi-Sadaghiani","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.22340-BIB0020|da22340-cit-0020","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/npp.2012.58","article-title":"Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial","volume":"37","author":"Sepanjnia","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.22340-BIB0021|da22340-cit-0021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cpr.2004.12.002","article-title":"Distinctions between bipolar and unipolar depression","volume":"25","author":"Cuellar","year":"2005","journal-title":"Clin Psychol Rev"},{"key":"10.1002\/da.22340-BIB0022|da22340-cit-0022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/da.22340-BIB0023|da22340-cit-0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1002\/da.22340-BIB0024|da22340-cit-0024","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/da.22340-BIB0025|da22340-cit-0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpsychires.2014.08.016","article-title":"L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial","volume":"59","author":"Zeinoddini","year":"2014","journal-title":"J Psychiat Res"},{"key":"10.1002\/da.22340-BIB0026|da22340-cit-0026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jad.2010.08.015","article-title":"Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania","volume":"129","author":"Amrollahi","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1002\/da.22340-BIB0027|da22340-cit-0027","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.20801","article-title":"Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression","volume":"28","author":"Abolfazli","year":"2011","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.22340-BIB0028|da22340-cit-0028","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1002\/da.22340-BIB0029|da22340-cit-0029","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jad.2013.11.003","article-title":"A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients","volume":"155","author":"Shahmansouri","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1002\/da.22340-BIB0030|da22340-cit-0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.psyneuen.2012.08.010","article-title":"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression","volume":"38","author":"Kashani","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.22340-BIB0031|da22340-cit-0031","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.06.011","article-title":"Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway","volume":"224","author":"Sadaghiani","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1002\/da.22340-BIB0032|da22340-cit-0032","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2753.2009.01280.x","article-title":"Hypoglycaemia with pioglitazone: analysis of data from the prescription-event monitoring study","volume":"16","author":"Vlckova","year":"2010","journal-title":"J Eval Clin Pract"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22340","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/da.22340\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T08:03:42Z","timestamp":1671523422000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22340"}},"subtitle":["Research Article: Pioglitazone for Bipolar Depression"],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22340","relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,23]]}}}